New Zealand Health Terminology Service (NZHTS) Implementation Guide
0.1.0 - ci-build

New Zealand Health Terminology Service (NZHTS) Implementation Guide, published by Health New Zealand | Te Whatu Ora. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/daniel-thomson/nzhts/ and changes regularly. See the Directory of published versions

ValueSet: NZ WHO testicular adnexa site histology

Official URL: https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-testicular-adnexa-site-histology Version: 0.1.0
Active as of 2024-11-11 Computable Name: canshare-who-testicular-adnexa-site-histology
Other Identifiers: http://canshare.co.nz/fhir/NamingSystem/valuesets#canshare-who-testicular-adnexa-site-histology

Histologies used for testicular adnexa sites, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) - Sections 7. Tumours of the testicular adnexa, 9. Neuroendocrine neoplasms, 11. Haematolymphoid tumours, 12. Melanocytic lesions or an 'Other' value.

References

This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

Logical Definition (CLD)

Generated Narrative: ValueSet canshare-who-testicular-adnexa-site-histology

version: 1; Last updated: 2024-11-05 17:14:30+1300; Language: en-x-sctlang-23162100-0210105

  • Include codes fromhttp://snomed.info/sct where constraint = ^300391000210108 |New Zealand World Health Organization classification of tumors 5th edition urinary and male genital testicular adnexa histology reference set| OR ^300411000210108 |New Zealand World Health Organization classification of tumors 5th edition urinary and male genital neuroendocrine histology reference set| OR ^300431000210101 |New Zealand World Health Organization classification of tumors 5th edition urinary and male genital hematolymphoid histology reference set| OR ^300441000210109 |New Zealand World Health Organization classification of tumors 5th edition urinary and male genital melanocytic lesion histology reference set| OR 74964007 |Other|

 

Expansion

Generated Narrative: ValueSet canshare-who-testicular-adnexa-site-histology

version: 1; Last updated: 2024-11-05 17:14:30+1300; Language: en-x-sctlang-23162100-0210105

Expansion based on SNOMED CT 21000210109 edition 01-Oct 2024

This value set contains 38 concepts

CodeSystemDisplay - English (English, en)
  2348006http://snomed.info/sctAdenomatoid tumour
  1187227004http://snomed.info/sctBenign adenomatous neoplasm
  253051001http://snomed.info/sctBenign Brenner tumour
  299651000210108http://snomed.info/sctBenign well-differentiated papillary mesothelioma
  30546008http://snomed.info/sctClear cell adenocarcinoma
  448546006http://snomed.info/sctCombined large cell neuroendocrine carcinoma
  47620003http://snomed.info/sctCystadenoma
  1172695008http://snomed.info/sctDiffuse large B cell lymphoma
  75987005http://snomed.info/sctEndometrioid adenoma, borderline malignancy
  30289006http://snomed.info/sctEndometrioid carcinoma
  65278006http://snomed.info/sctEpithelioid mesothelioma, malignant
  51747000http://snomed.info/sctExtra-adrenal paraganglioma
  397350003http://snomed.info/sctExtranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue
  262481000210107http://snomed.info/sctJuvenile xanthogranuloma
  128628002http://snomed.info/sctLarge cell neuroendocrine carcinoma
  1186968006http://snomed.info/sctMalignant adenomatous neoplasm
  1513001http://snomed.info/sctMelanotic neuroectodermal tumour
  30383009http://snomed.info/sctMesothelioma, biphasic, malignant
  62064005http://snomed.info/sctMesothelioma, malignant
  785766008http://snomed.info/sctMixed neuroendocrine-non neuroendocrine neoplasm
  79143006http://snomed.info/sctMucinous cystadenocarcinoma
  67182003http://snomed.info/sctMucinous cystadenoma
  128852007http://snomed.info/sctMucinous cystic tumour of borderline malignancy
  301341000210107http://snomed.info/sctMucosal melanoma
  733844008http://snomed.info/sctNeuroendocrine type combined small cell carcinoma
  2142002http://snomed.info/sctNodular melanoma
  74964007http://snomed.info/sctOther
  32140001http://snomed.info/sctPapillary cystadenoma
  128921005http://snomed.info/sctPlasmacytoma, extramedullary (not occurring in bone)
  399477001http://snomed.info/sctSarcomatoid mesothelioma
  301241000210101http://snomed.info/sctSerous cystadenocarcinoma
  51608009http://snomed.info/sctSerous cystadenoma
  128849004http://snomed.info/sctSerous cystadenoma, borderline malignancy
  74364000http://snomed.info/sctSmall cell neuroendocrine carcinoma
  1162767002http://snomed.info/sctSquamous cell carcinoma
  1286768001http://snomed.info/sctWell-differentiated neuroendocrine tumour
  1286769009http://snomed.info/sctWell-differentiated neuroendocrine tumour grade 1
  1286770005http://snomed.info/sctWell-differentiated neuroendocrine tumour grade 2

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code